1. Home
  2. STVN vs LUMN Comparison

STVN vs LUMN Comparison

Compare STVN & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • LUMN
  • Stock Information
  • Founded
  • STVN 1949
  • LUMN 1968
  • Country
  • STVN Italy
  • LUMN United States
  • Employees
  • STVN N/A
  • LUMN N/A
  • Industry
  • STVN Containers/Packaging
  • LUMN Telecommunications Equipment
  • Sector
  • STVN Consumer Discretionary
  • LUMN Telecommunications
  • Exchange
  • STVN Nasdaq
  • LUMN Nasdaq
  • Market Cap
  • STVN 6.2B
  • LUMN 5.1B
  • IPO Year
  • STVN 2021
  • LUMN 1972
  • Fundamental
  • Price
  • STVN $26.23
  • LUMN $5.85
  • Analyst Decision
  • STVN Buy
  • LUMN Buy
  • Analyst Count
  • STVN 4
  • LUMN 7
  • Target Price
  • STVN $25.13
  • LUMN $5.12
  • AVG Volume (30 Days)
  • STVN 414.5K
  • LUMN 15.9M
  • Earning Date
  • STVN 11-04-2025
  • LUMN 11-04-2025
  • Dividend Yield
  • STVN 0.24%
  • LUMN N/A
  • EPS Growth
  • STVN 6.78
  • LUMN N/A
  • EPS
  • STVN 0.57
  • LUMN N/A
  • Revenue
  • STVN $1,344,798,591.00
  • LUMN $12,824,000,000.00
  • Revenue This Year
  • STVN $8.24
  • LUMN N/A
  • Revenue Next Year
  • STVN $10.38
  • LUMN N/A
  • P/E Ratio
  • STVN $45.99
  • LUMN N/A
  • Revenue Growth
  • STVN 5.28
  • LUMN N/A
  • 52 Week Low
  • STVN $17.12
  • LUMN $3.01
  • 52 Week High
  • STVN $28.00
  • LUMN $10.33
  • Technical
  • Relative Strength Index (RSI)
  • STVN 61.46
  • LUMN 65.80
  • Support Level
  • STVN $25.40
  • LUMN $4.57
  • Resistance Level
  • STVN $27.41
  • LUMN $6.65
  • Average True Range (ATR)
  • STVN 1.33
  • LUMN 0.44
  • MACD
  • STVN 0.45
  • LUMN 0.11
  • Stochastic Oscillator
  • STVN 80.07
  • LUMN 61.30

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About LUMN Lumen Technologies Inc.

With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 have shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen has announced the sale of its consumer fiber network, but will maintain and harvest its legacy consumer copper network.

Share on Social Networks: